205 related articles for article (PubMed ID: 15632045)
1. Regulation of hepatobiliary transport activity and noninvasive identification of cytokine-dependent liver inflammation.
Joseph B; Bhargava KK; Tronco GG; Kumaran V; Palestro CJ; Gupta S
J Nucl Med; 2005 Jan; 46(1):146-52. PubMed ID: 15632045
[TBL] [Abstract][Full Text] [Related]
2. Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin.
Bhargava KK; Joseph B; Ananthanarayanan M; Balasubramaniyan N; Tronco GG; Palestro CJ; Gupta S
J Nucl Med; 2009 Jul; 50(7):1140-6. PubMed ID: 19525466
[TBL] [Abstract][Full Text] [Related]
3. Systemic and local release of inflammatory cytokines regulates hepatobiliary excretion of 99mTc-mebrofenin.
Joseph B; Bhargava KK; Tronco GG; Palestro CJ; Gupta S
Nucl Med Commun; 2008 Apr; 29(4):336-44. PubMed ID: 18317297
[TBL] [Abstract][Full Text] [Related]
4. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green.
de Graaf W; Häusler S; Heger M; van Ginhoven TM; van Cappellen G; Bennink RJ; Kullak-Ublick GA; Hesselmann R; van Gulik TM; Stieger B
J Hepatol; 2011 Apr; 54(4):738-45. PubMed ID: 21163547
[TBL] [Abstract][Full Text] [Related]
5. Hepatobiliary clearance of labelled mebrofenin in normal and D-galactosamine HCl-induced hepatitis rats and the protective effect of turmeric extract.
Deshpande UR; Joseph LJ; Samuel AM
Indian J Physiol Pharmacol; 2003 Jul; 47(3):332-6. PubMed ID: 14723320
[TBL] [Abstract][Full Text] [Related]
6. In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
Neyt S; Huisman MT; Vanhove C; De Man H; Vliegen M; Moerman L; Dumolyn C; Mannens G; De Vos F
J Nucl Med; 2013 Apr; 54(4):624-30. PubMed ID: 23440558
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of hepatic function during liver regeneration in a standardized rat model.
de Graaf W; Bennink RJ; Heger M; Maas A; de Bruin K; van Gulik TM
J Nucl Med; 2011 Feb; 52(2):294-302. PubMed ID: 21233172
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-mebrofenin scintigraphy for evaluating liver disease in a rat model of Wilson's disease.
Malhi H; Bhargava KK; Afriyie MO; Volenberg I; Schilsky ML; Palestro CJ; Gupta S
J Nucl Med; 2002 Feb; 43(2):246-52. PubMed ID: 11850492
[TBL] [Abstract][Full Text] [Related]
9. (99m)Tc sulfur colloid and (99m)Tc mebrofenin hepatobiliary functional liver imaging in normal and diabetic rats.
Al-Saeedi F; Loutfi I
Med Princ Pract; 2011; 20(2):129-32. PubMed ID: 21252566
[TBL] [Abstract][Full Text] [Related]
10. (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy.
de Graaf W; van Lienden KP; van Gulik TM; Bennink RJ
J Nucl Med; 2010 Feb; 51(2):229-36. PubMed ID: 20080899
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model.
Veteläinen RL; Bennink RJ; de Bruin K; van Vliet A; van Gulik TM
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1107-14. PubMed ID: 16738848
[TBL] [Abstract][Full Text] [Related]
12. Hepatic extraction efficiency of technetium-99m-mebrofenin in the dog with toxic-induced acute liver disease.
Daniel GB; DeNovo RC; Schultze AE; Schmidt D; Smith GT
J Nucl Med; 1998 Jul; 39(7):1286-92. PubMed ID: 9669412
[TBL] [Abstract][Full Text] [Related]
13. Experimental toxic liver damage and hepatic plasma clearance of 99mTc-mebrofenin (iminodiacetate derivative). II. Recovery from the acute, CCl4-induced liver damage.
Kapuściński J; Kuroszczyk J; Liniecki J; Bieńkiewicz M; Zieliński K; Tuszyner K
Pol J Occup Med Environ Health; 1993; 6(4):399-408. PubMed ID: 8019202
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathway-specific 99mTc-N-(3-bromo-2,4,6-trimethyacetanilide) iminodiacetic acid liver imaging to assess innate immune responses induced by cell transplantation.
Joseph B; Bhargava KK; Tronco GG; Palestro CJ; Gupta S
Nucl Med Commun; 2009 Feb; 30(2):126-33. PubMed ID: 19077914
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in-vivo evaluation of 99mTc-IOTIDA for cholescintigraphy.
Hong YD; Jang BS; Choi SM; Park WW; Park KB; Choi SJ
Appl Radiat Isot; 2004 Dec; 61(6):1273-8. PubMed ID: 15388121
[TBL] [Abstract][Full Text] [Related]
16. (99m)Tc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of a single sample plasma and hepatic clearance of (99m)Tc-HEPIDA for assessment of hepatic parenchyma performance.
Surma MJ; Frieske I; Jencz K; Kuźmierek J
Nucl Med Rev Cent East Eur; 2006; 9(2):125-31. PubMed ID: 17304475
[TBL] [Abstract][Full Text] [Related]
17. Comparison of (99m)Tc-HEPIDA and (99m)Tc-MBrIDA from the standpoint of hepatic clearance determination-- preliminary communication.
Surma MJ; Deroń Z; Frieske I; Pietrzak-Stelmasiak E; Kuśmierek J
Nucl Med Rev Cent East Eur; 2009; 12(2):72-7. PubMed ID: 20235057
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of fibrosis in chronic hepatitis: histopathological correlation.
Kula M; Karacavus S; Baskol M; Deniz K; Abdulrezzak U; Tutus A
Nucl Med Commun; 2010 Apr; 31(4):280-5. PubMed ID: 20087241
[TBL] [Abstract][Full Text] [Related]
19. Hepatic extraction efficiency and excretion rate of technetium-99m-mebrofenin in dogs.
Daniel GB; Bahr A; Dykes JA; DeNovo R; Young K; Smith GT
J Nucl Med; 1996 Nov; 37(11):1846-9. PubMed ID: 8917190
[TBL] [Abstract][Full Text] [Related]
20. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.
Ghibellini G; Leslie EM; Pollack GM; Brouwer KL
Pharm Res; 2008 Aug; 25(8):1851-60. PubMed ID: 18509604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
